Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (411-420 of 1,126) with videos related to

Pageof 113
Sort By:
Human Molecular Genetics|February 23, 2013
Gata3 antagonizes cancer progression in Pten-deficient prostatesAlana H T Nguyen, Mathieu Tremblay, Katharina Haigh, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 20, 2018
Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinomaSebastiano Nazzani, Elio Mazzone, Felix Preisser, et al.
European Urology|November 13, 2007
High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancerClaudio Jeldres, Nazareno Suardi, Fred Saad, et al.
Prostate Cancer and Prostatic Diseases|September 13, 2022
Association of dynamic change in patient-reported pain with survival in metastatic castrate sensitive prostate cancer-exploratory analysis of LATITUDE studySoumyajit Roy, Scott C Morgan, Christopher J D Wallis, et al.
The Prostate|April 18, 2023
Implications of metastatic stage at presentation in docetaxel naïve metastatic castrate resistant prostate cancerSoumyajit Roy, Christopher J D Wallis, Scott C Morgan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2010
Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castration-resistant prostate cancerKim N Chi, Sebastien J Hotte, Evan Y Yu, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 31, 2020
Canadian Urological Association-Canadian Urologic Oncology Group guideline on metastatic castration-naive and castration-sensitive prostate cancerAlan I So, Kim N Chi, Brita Danielson, et al.
Clinical Genitourinary Cancer|April 16, 2023
Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate CancerDaniel J George, Fred Saad, Michael S Cookson, et al.
Urology|April 21, 2009
Population-based analysis of normal Total PSA and percentage of free/Total PSA values: results from screening cohortUmberto Capitanio, Paul Perrotte, Laurent Zini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2020
Small Renal Masses With Tumor Size 0 to 2 cm: A SEER-Based Study and Validation of NCCN GuidelinesAngela Pecoraro, Giuseppe Rosiello, Stefano Luzzago, et al.
Pageof 113

Showing results (411-420 of 1,126) with videos related to

Sort By:
Pageof 113
Human Molecular Genetics|February 23, 2013
Gata3 antagonizes cancer progression in Pten-deficient prostatesAlana H T Nguyen, Mathieu Tremblay, Katharina Haigh, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 20, 2018
Rates of lymph node invasion and their impact on cancer specific mortality in upper urinary tract urothelial carcinomaSebastiano Nazzani, Elio Mazzone, Felix Preisser, et al.
European Urology|November 13, 2007
High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancerClaudio Jeldres, Nazareno Suardi, Fred Saad, et al.
Prostate Cancer and Prostatic Diseases|September 13, 2022
Association of dynamic change in patient-reported pain with survival in metastatic castrate sensitive prostate cancer-exploratory analysis of LATITUDE studySoumyajit Roy, Scott C Morgan, Christopher J D Wallis, et al.
The Prostate|April 18, 2023
Implications of metastatic stage at presentation in docetaxel naïve metastatic castrate resistant prostate cancerSoumyajit Roy, Christopher J D Wallis, Scott C Morgan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 25, 2010
Randomized phase II study of docetaxel and prednisone with or without OGX-011 in patients with metastatic castration-resistant prostate cancerKim N Chi, Sebastien J Hotte, Evan Y Yu, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 31, 2020
Canadian Urological Association-Canadian Urologic Oncology Group guideline on metastatic castration-naive and castration-sensitive prostate cancerAlan I So, Kim N Chi, Brita Danielson, et al.
Clinical Genitourinary Cancer|April 16, 2023
Impact of Concomitant Prostate Cancer Medications on Efficacy and Safety of Relugolix Versus Leuprolide in Men With Advanced Prostate CancerDaniel J George, Fred Saad, Michael S Cookson, et al.
Urology|April 21, 2009
Population-based analysis of normal Total PSA and percentage of free/Total PSA values: results from screening cohortUmberto Capitanio, Paul Perrotte, Laurent Zini, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2020
Small Renal Masses With Tumor Size 0 to 2 cm: A SEER-Based Study and Validation of NCCN GuidelinesAngela Pecoraro, Giuseppe Rosiello, Stefano Luzzago, et al.
Pageof 113